potential of platinum-free treatment approaches in patients with muc
Published 1 year ago • 31 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:12
treatment sequencing in patients with muc who have relapsed on ici
-
1:40
neo trial: neoadjuvant olaparib in platinum-sensitive relapsed high-grade serous ovarian cancer
-
10:11
emerging treatment options for platinum-sensitive ovarian cancer
-
6:36
atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy ...
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
28:44
updates on promising progress in platinum resistant ovarian cancer
-
35:35
maximizing the potential of parp inhibitors as first-line maintenance therapy in ovarian cancer
-
4:00
mirvetuximab soravtansine shows promise in frα-positive, platinum-sensitive ovarian cancer
-
50:32
precision medicine for ovarian cancer (2021)
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
25:20
ovarian cancer 2021: recent advance in treatment
-
26:02
updates in ovarian cancer: frontline maintenance
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
9:22
rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian ...
-
4:07
expert approaches for treating recurrent ovarian cancer
-
16:37
managing treatment side effects and maintaining quality of life for patients with ovarian cancer
-
0:43
efficacy of niraparib on pfs in patients with recurrent ovarian cancer
-
1:38
results of trias 2009 trial of sorafenib with topotecan in ovarian cancer
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
59:55
tackling platinum resistant ovarian cancer
-
2:25
results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer